Full Organized List of Psychedelic Science 2017 Videos

April 2017 · 7 minute read

Thank you to MAPS, Beckley, all presenters and volunteers, and everyone else involved.

It is an exciting time for psychedelic research.

To make it easy to browse the Psychedelic Science 2017 talks according to the schedule, I went through the PDF schedules for Friday, Saturday and Sunday and re-created the schedule, with added video links. All talks are color coded for categorical browsing where relevant.


Full Schedule for Friday 2017

East Hall

09:00 - 10:00 PLENARY: Conference Welcome with Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD

10:00 - 10:30 PLENARY: Stanislav Grof, MD, PhD Psychedelics and the Future of Humanity

10:30 - 11:00 Break

11:00 - 12:00 Stanislav Grof, MD, PhD, The Implications of Consciousness Research for Psychiatry, Psychology, and Psychotherapy, Clinical

12:00 - 12:30 Stanislav Grof, MD, PhD. Supplemental Q&A (Same link as above)

12:30 - 2:00 Break

2:00 - 2:30 Amanda Feilding, From Taboo to Treatment: The Evolution of Psychedelic Medicine, Clinical

2:30 - 3:00 David Nutt, MD, Psychedelic Research: From Brain Imaging to Policy Reform, Clinical

3:00 - 3:30 Mendel Kaelen, PhDc, The Psychological and Neurophysiological Effects of Music in Combination with Psychedelics, Clinical

3:30 - 4:00 Leor Roseman, MSc, Psilocybin-Assisted Therapy: Neural Changes and the Relationship Between the Acute Peak Experience and Clinical Outcomes, Clinical

4:00 - 4:30 Break

4:30 - 5:30 Jordi Riba, PhD, New Findings from Ayahuasca Research: From Enhancing Mindfulness Abilities to Promoting Neurogenesis, Clinical

5:30 - 6:30 PLENARY PANEL: Ken Tupper, PhD, Ethan Nadelmann, PhD, David Nutt, MD, and Ben de Loenen, moderated by Natalie Ginsberg, Psychedelics and Policy

Grand Ballroom

09:00 - 11:00 See East Hall

11:00 - 11:30 Anya Loizaga-Velder, PhD, Evaluating the Efficacy of Ayahuasca-Assisted Treatment for Substance Dependency, Plant

11:30 - 12:00 Luís Fernando Tófoli, PhD, Treating Alcohol-Related Disorders with Ayahuasca, Plant

12:00 - 12:30 Dráulio Barros de Araújo, PhD, Rapid Antidepressant Effects of the Psychedelic Ayahuasca in Treatment-Resistant Depression: A Randomized Placebo-Controlled Trial, Plant

12:30 - 2:00 Break

2:00 - 3:00 Gabor Maté, MD, From Jungle To “Civilization”: How Plant Medicines Can Promote Health In a Toxic Culture, Plant

3:00 - 4:00 James Fadiman, PhD, and Sophia Korb, PhD, Microdosing: The Phenomenon, Research Results, and Startling Surprises, Interdisciplinary

4:00 - 4:30 Break

4:30 - 5:00 Bob Jesse, Psychedelics: The Uncertain Paths from Re-emergence to Renaissances, Interdisciplinary

5:00 - 5:30 Vanja Palmers, The Dependent Co-Arising of Psychedelics and Meditation, Clinical

5:30 - 6:30 See East Hall


Full Schedule for Saturday 2017

East Hall

09:00 - 09:30 David Nichols, PhD, Psychedelic Neuroscience LSD Gives Up a Secret, Clinical

09:30 - 10:00 Franz Vollenweider, MD, Psychedelic 5HT2A Receptor Agonists Enhance Mood and Empathy and Reduce Social Pain in Healthy Humans: Implication for Mood Disorders, Clinical

10:00 - 10:30 David Nichols, PhD, and Franz Vollenweider, MD, Q&A: Psychedelic Neuroscience, Clinical

10:30 - 11:00 Break

11:00 - 11:30 Boris Heifets, MD, PhD, Toward Single Shot Therapy for Neuropsychiatric Disorders, Clinical

11:30 - 12:30 Charles Grob, MD, and Alicia Danforth, PhD, MDMA-Assisted Therapy for Social Anxiety in Autistic Adults: Lessons from Phase 2 Clinical Research, Clinical

12:30 - 2:00 Break

2:00 - 3:00 Marcela Ot’alora, MA, LPC, and Bruce Poulter, RN, MPH, MDMA as Profound Change Agent: Insights from MDMA-Assisted Psychotherapy for PTSD Research, Clinical

3:00 - 4:00 Michael Mithoefer, MD, and Annie Mithoefer, BSN, MDMA-Assisted Psychotherapy for PTSD: Lessons from Phase 2 Clinical Trials, Clinical

4:00 - 4:30 Break

4:30 - 5:00 Phil Wolfson, MD, and Julane Andries, MFT, MDMA-Assisted Psychotherapy for Anxiety in Life-Threatening Illness, Clinical

5:00 - 5:30 Ben Sessa, MD, MDMA Therapy: A Child Psychiatrist’s Perspective, Clinical

5:30 - 6:00 Anne Wagner, PhD, Combining Cognitive Behavioral Conjoint Therapy for PTSD and MDMA: First Cases and Understanding the MDMA Experience from a Cognitive Behavioral Framework, Clinical

6:00 - 6:45 PLENARY PANEL: Paul Summergrad, MD, and Thomas Insel, MD, moderated by George Goldsmith, Future of Psychedelic Psychiatry

Grand Ballroom

9:00 - 9:30 Torsten Passie, MD, PhD, History of MDMA: An Overview, Clinical

9:30 - 10:00 Kim Kuypers, PhD, Neurobiological Mechanisms Underlying the Prosocial Effects of MDMA, Clinical

10:00 - 10:30 Harriet de Wit, PhD, Ecstasy in the Laboratory: Recent Advances in MDMA Research, Clinical

10:30 - 11:00 Break

11:00 - 12:00 PANEL: Study Volunteers, Discussion of UW Psilocybin Pharmacokinetics Study, Interdisciplinary

12:00 - 12:30 Rainer Krähenmann, MD, New Findings from the University of Zurich Studies Into the Mechanism of Action of Psilocybin and LSD: Relevance for Treatment of Major Depression and for Enhancement of Psychotherapy, Interdisciplinary

12:30 - 2:00 Break

2:00 - 3:00 Sandor Iron Rope, Indigenous Perspectives on Peyote’s Healing Potentials and Conservation Challenges, Plant. No video available, it appears this talk may not have happened.

3:00 - 3:30 Ben Feinberg, PhD, Conflict and Transformation in Mazatec and Outsiders’ Views of the Therapeutic Value of Mushroom Use in Huautla, Plant

3:30 - 4:00 Kathleen Harrison, MA, Cannabis and Spirituality: Exploring the Plant-Human-Spirit Relationship, Plant

4:00 - 4:30 Break

4:30 - 5:00 Eduardo Schenberg, PhD, Bringing MDMA-Assisted Psychotherapy to Brazil, Interdisciplinary

5:00 - 7:00 Break

7:00 - 11:00 Psychedelic Comedy Banquet


Full Schedule for Saturday 2017

No individual links for Sunday videos yet, so links are to the entire day.

East Hall

09:00 - 09:30 Albert Garcia-Romeu, PhD, Optimizing Psilocybin Dosing for Clinical Precision: The Case for Weight-Adjusted Dosing, Clinical

09:30 - 10:00 Darrick May, Examining “Bad Trips”: Acute and Enduring Positive and Negative Consequences of Challenging Experiences with Psilocybin, Clinical

10:00 - 10:30 Frederick Barrett, Neural Correlates of Responses to Psilocybin During Meditation and Music Listening, Clinical

10:30 - 11:00 Break

11:00 - 12:00 Roland Griffiths, PhD, Johns Hopkins Psilocybin Research Project: Studies of Mystical Experience, Adverse Effects, Meditation in Healthy Volunteers, and Palliative Effects in Cancer Patients—Implications for Spirituality and Therapeutics, Clinical

12:00 - 12:30 Mary Cosimano, MSW, Love and Connection in Psilocybin-Facilitated Mystical Experience Research, Clinical

12:30 - 2:00 Break

2:00 - 3:00 Matthew Johnson, PhD, Psychedelics as Behavior Change Agents: Addiction Recovery and Beyond, Clinical

3:00 - 3:30 Michael Bogenschutz, MD, Psychedelic-Assisted Treatment of Alcohol Use Disorder: A Clinical Perspective, Clinical

3:30 - 4:00 Anthony Bossis, PhD, The Varieties of Religious Leaders’ Experiences: The NYU Clinical Trial on Psilocybin-Generated Mystical Experience in Religious Leaders, Clinical

4:00 - 4:30 Break

4:30 - 5:30 Stephen Ross, PhD, and Gabby Agin-Liebes, PhDc, Psilocybin for Cancer-Related Anxiety and Depression: NYU Phase 2 Randomized Controlled Trial and Proposed Mechanisms, Clinical

5:30 - 6:00 Rosalind Watts, MD, Patient Reports of Increased Connection to Self, Others, and World After Psilocybin for Treatment-Resistant Depression, Clinical

6:00 - 6:30 PLENARY: Conference Video and Closing Remarks with Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD

Grand Ballroom

09:00 - 09:30 José Carlos Bouso, PhD, What Do the Spirits Do? Towards an Understanding of the Psychological Mechanisms of Transformation, Plant

09:30 - 10:00 Sidarta Ribeiro, PhD, Whole Organisms or Pure Compounds? Entourage Effect versus Drug Specificity, Plant

10:00 - 10:30 Jordan Sloshower, MD, Integrating Plant Medicines and Psychiatry: Theory and Methods of a Model Clinic, Plant

10:30 - 11:00 Break

11:00 - 12:00 PANEL: Phil Wolfson, MD, Raquel Bennett, PsyD, Chadi Abdallah, MD, Richard Roston, MD, and Alison McInnes, MD, Ketamine Therapy, Interdisciplinary

12:00 - 12:30 John Hartberg, BSc, MDc, Ketamine’s Therapeutic Potential: Practical Considerations for Clinical Use, Interdisciplinary

12:30 - 2:00 Break

2:00 - 2:30 Emilia Sanabria, Healing Encounters: Ayahuasca and the Politics of Knowledge, Plant

2:30 - 3:00 Rachel Harris, PhD, Listening to Ayahuasca: New Hope for Depression, Addiction, PTSD, and Anxiety, Plant

3:00 - 3:30 Dennis McKenna, PhD, Beyond Ayahuasca: Occurrence and Biological Activities of Some Naturally Occurring ß-carbolines, Plant

3:30 - 4:00 Paul Stamets, Psilocybin Mushrooms and The Mycology of Consciousness, Interdisciplinary

4:00 - 4:30 Break

4:30 - 5:00 Jessica Nielson, PhD, Ayahuasca for Posttraumatic Stress Disorder: Assessing Risks and Benefits through Anonymous Community Feedback, Plant

5:00 - 5:30 Stephens Rehen, PhD, Biological Effects of Ayahuasca in Human Neural Stem Cells and Minibrains, Plant

5:30 - 6:00 Jordi Riba, PhD, Salvinorin-A: A Perception-Modifying Drug with a Unique Neurophysiological Profile, Plant

6:00 - 6:30 See East Hall

Extra, from Junior Ballroom, Scientists I Have Known and Loved: A Conversation with Ann Shulgin, Moderated by Tania Manning, Interdisciplinary